France considers herbal changes
This article was originally published in OTC Bulletin & The Rose Sheet
The French Senate is considering ways to improve the country’s medicinal plants market by expanding the medicinal list of plants available OTC and liberalising distribution rules. The Senate received a report on a fact-finding mission to highlight the potential of medicinal plants and herbal remedies both in local areas in France and in the country’s overseas territories.
You may also be interested in...
The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.
To aid its value assessments, ICER is interested in helping FDA understand the importance of patient-relevant outcomes and consistent endpoints across trials of drugs for the same disease.